moxifloxacin has been researched along with Legionellosis in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Chen, JY; Li, X; Tong, B; Wang, JY | 1 |
Dugar, M; Rankin, WA; Rowe, E; Smith, MD | 1 |
Arvis, P; Fritsch, A; Garau, J; Read, RC | 1 |
Lück, PC; Steinert, M | 1 |
Bernard, K; Burdz, T; Garceau, R; Martinez, G; Reimer, A; Vinh, DC; Wiebe, D | 1 |
Adrián, F; del Campo, R; García, C; Gómez-Lus, P; Gómez-Lus, R; Rubio, MC; Sánchez, S | 1 |
2 review(s) available for moxifloxacin and Legionellosis
Article | Year |
---|---|
[Pathogenesis, diagnosis and therapy of Legionella infections].
Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Aza Compounds; Azithromycin; Ciprofloxacin; Diagnosis, Differential; DNA, Bacterial; Fluoroquinolones; Humans; Incidence; Legionella; Legionella pneumophila; Legionellosis; Legionnaires' Disease; Levofloxacin; Moxifloxacin; Ofloxacin; Polymerase Chain Reaction; Quinolines; Serotyping; Virulence | 2006 |
Legionella jordanis lower respiratory tract infection: case report and review.
Topics: Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Legionella; Legionellosis; Male; Middle Aged; Molecular Sequence Data; Moxifloxacin; Quinolines | 2007 |
4 other study(ies) available for moxifloxacin and Legionellosis
Article | Year |
---|---|
Epileptic Seizure after Use of Moxifloxacin in Man with Legionella longbeachae Pneumonia.
Topics: China; Epilepsy; Humans; Legionella longbeachae; Legionellosis; Male; Middle Aged; Moxifloxacin; Pneumonia, Bacterial; Seizures | 2020 |
"My foot hurts": a flare of rheumatoid arthritis?
Topics: Arthritis, Rheumatoid; Aza Compounds; Azithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Legionella longbeachae; Legionellosis; Male; Middle Aged; Moxifloxacin; Neutropenia; Osteomyelitis; Quinolines; Steroids | 2009 |
Clinical efficacy of moxifloxacin versus comparator therapies for community-acquired pneumonia caused by Legionella spp.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Legionella; Legionellosis; Male; Middle Aged; Moxifloxacin; Multicenter Studies as Topic; Pneumonia, Bacterial; Quinolines; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Legionella; Legionellosis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifampin | 2001 |